These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1421426)

  • 1. Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells.
    Goldfine ID; Papa V; Vigneri R; Siiteri P; Rosenthal S
    Breast Cancer Res Treat; 1992; 22(1):69-79. PubMed ID: 1421426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II.
    Papa V; Hartmann KK; Rosenthal SM; Maddux BA; Siiteri PK; Goldfine ID
    Mol Endocrinol; 1991 May; 5(5):709-17. PubMed ID: 1649393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
    Pandini G; Vigneri R; Costantino A; Frasca F; Ippolito A; Fujita-Yamaguchi Y; Siddle K; Goldfine ID; Belfiore A
    Clin Cancer Res; 1999 Jul; 5(7):1935-44. PubMed ID: 10430101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I insulin-like growth factor receptor function in breast cancer.
    Surmacz E; Guvakova MA; Nolan MK; Nicosia RF; Sciacca L
    Breast Cancer Res Treat; 1998 Feb; 47(3):255-67. PubMed ID: 9516080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors and breast cancer.
    Fürstenberger G; Morant R; Senn HJ
    Onkologie; 2003 Jun; 26(3):290-4. PubMed ID: 12845216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
    Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
    Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.
    Belfiore A; Pandini G; Vella V; Squatrito S; Vigneri R
    Biochimie; 1999 Apr; 81(4):403-7. PubMed ID: 10401676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
    Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
    Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
    Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL
    Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.
    Motallebnezhad M; Aghebati-Maleki L; Jadidi-Niaragh F; Nickho H; Samadi-Kafil H; Shamsasenjan K; Yousefi M
    Tumour Biol; 2016 Sep; 37(9):11711-11721. PubMed ID: 27444280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.